Mitral Valve Repair in Degenerative Mitral Regurgitation: State of the Art

M De Bonis, O Alfieri, M Dalrymple-Hay, B Del Forno, F Dulguerov, G Dreyfus

Research output: Contribution to journalArticle

Abstract

In industrialized countries, the most common etiology of mitral regurgitation (MR) is degenerative mitral valve (MV) disease. The natural history of severe degenerative MR is poor. However, its appropriate and timely correction is associated with a life expectancy similar to that of the normal population. Surgical MV repair is the gold standard treatment. This review will focus on the most recent evidence with a specific emphasis on surgical indications, timing of treatment, contemporary surgical techniques, Heart Teams and Centers of Excellence. © 2017 Elsevier Inc.
Original languageEnglish
Pages (from-to)386-393
Number of pages8
JournalProgress in Cardiovascular Diseases
Volume60
Issue number3
DOIs
Publication statusPublished - 2017

Fingerprint

Mitral Valve Insufficiency
Mitral Valve
Life Expectancy
Developed Countries
Surgical Instruments
Population

Cite this

Mitral Valve Repair in Degenerative Mitral Regurgitation: State of the Art. / De Bonis, M; Alfieri, O; Dalrymple-Hay, M; Del Forno, B; Dulguerov, F; Dreyfus, G.

In: Progress in Cardiovascular Diseases, Vol. 60, No. 3, 2017, p. 386-393.

Research output: Contribution to journalArticle

De Bonis, M ; Alfieri, O ; Dalrymple-Hay, M ; Del Forno, B ; Dulguerov, F ; Dreyfus, G. / Mitral Valve Repair in Degenerative Mitral Regurgitation: State of the Art. In: Progress in Cardiovascular Diseases. 2017 ; Vol. 60, No. 3. pp. 386-393.
@article{6f4dcbeaa8a747c0930cd2a409b3d09d,
title = "Mitral Valve Repair in Degenerative Mitral Regurgitation: State of the Art",
abstract = "In industrialized countries, the most common etiology of mitral regurgitation (MR) is degenerative mitral valve (MV) disease. The natural history of severe degenerative MR is poor. However, its appropriate and timely correction is associated with a life expectancy similar to that of the normal population. Surgical MV repair is the gold standard treatment. This review will focus on the most recent evidence with a specific emphasis on surgical indications, timing of treatment, contemporary surgical techniques, Heart Teams and Centers of Excellence. {\circledC} 2017 Elsevier Inc.",
author = "{De Bonis}, M and O Alfieri and M Dalrymple-Hay and {Del Forno}, B and F Dulguerov and G Dreyfus",
year = "2017",
doi = "10.1016/j.pcad.2017.10.006",
language = "English",
volume = "60",
pages = "386--393",
journal = "Progress in Cardiovascular Diseases",
issn = "0033-0620",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Mitral Valve Repair in Degenerative Mitral Regurgitation: State of the Art

AU - De Bonis, M

AU - Alfieri, O

AU - Dalrymple-Hay, M

AU - Del Forno, B

AU - Dulguerov, F

AU - Dreyfus, G

PY - 2017

Y1 - 2017

N2 - In industrialized countries, the most common etiology of mitral regurgitation (MR) is degenerative mitral valve (MV) disease. The natural history of severe degenerative MR is poor. However, its appropriate and timely correction is associated with a life expectancy similar to that of the normal population. Surgical MV repair is the gold standard treatment. This review will focus on the most recent evidence with a specific emphasis on surgical indications, timing of treatment, contemporary surgical techniques, Heart Teams and Centers of Excellence. © 2017 Elsevier Inc.

AB - In industrialized countries, the most common etiology of mitral regurgitation (MR) is degenerative mitral valve (MV) disease. The natural history of severe degenerative MR is poor. However, its appropriate and timely correction is associated with a life expectancy similar to that of the normal population. Surgical MV repair is the gold standard treatment. This review will focus on the most recent evidence with a specific emphasis on surgical indications, timing of treatment, contemporary surgical techniques, Heart Teams and Centers of Excellence. © 2017 Elsevier Inc.

U2 - 10.1016/j.pcad.2017.10.006

DO - 10.1016/j.pcad.2017.10.006

M3 - Article

VL - 60

SP - 386

EP - 393

JO - Progress in Cardiovascular Diseases

JF - Progress in Cardiovascular Diseases

SN - 0033-0620

IS - 3

ER -